By understanding the precise molecular mechanism by which pVHL regulates mitochondrial mass, we performed pharmacological studies to increase mitochondrial content in VHL-deficient ccRCC cells. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.